Abiopharma

🔍 Lipschultz Tyler (Director)

Company: Xtant Medical Holdings, Inc. (XTNT)

Report Date: 2026-08-15

Detailed Transactions and Holdings:

• Acquired 215,517 shares of Common Stock (Direct)
  Date: 2026-08-15 | Code: A | equity_swap_involved: 0 | shares_owned_after: 373,745.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: These shares are subject to a restricted stock unit (RSU) award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan and will vest on August 15, 2027, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
• F2: Includes 373,745 shares issuable upon vesting of RSUs granted under the Xtant Medial Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining a director of Xtant through the respective vesting date.